Amphotericin B in the management of fungal infections in a neonatal intensive care unit: experiences in a teaching hospital (original) (raw)
Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations
Itamar Shalit
Journal of Antimicrobial Chemotherapy, 2003
View PDFchevron_right
Use of Antifungals Other Than Amphotericin B for Invasive Fungal Infections in Neonates and Children
Jeeson Unni
Pediatric Infectious Disease, 2021
View PDFchevron_right
Oral amphotericin B for the prevention of Candida bloodstream infection in critically ill children*
Shai Ashkenazi
Pediatric Critical Care Medicine, 2006
View PDFchevron_right
A Randomized, Double-Blind, Prospective Study of Caspofungin vs. Amphotericin B for the Treatment of Invasive Candidiasis in Newborn Infants
Mahmoud Ismail
Journal of Tropical Pediatrics, 2012
View PDFchevron_right
A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants with Invasive Candidiasis
Laura Kovanda
The Pediatric infectious disease journal, 2018
View PDFchevron_right
Candidemia profile and antifungal drugs susceptibility pattern in neonatal intensive care unit patients in a tertiary care teaching institute in Maharashtra
shilpa putta
Annals of Pathology and Laboratory Medicine, 2017
View PDFchevron_right
Antifungal Therapy and Outcomes in Infants With Invasive Candida Infections
Daniel K. Benjamin
The Pediatric Infectious Disease Journal, 2012
View PDFchevron_right
Invasive fungal infection in neonatal intensive care units: a multicenter survey
Teresa Tomé
Journal of chemotherapy (Florence, Italy), 2014
View PDFchevron_right
Fungal Infections in Neonatal Intensive Care
Henrique Pereira Neves
Selected Topics in Neonatal Care, 2018
View PDFchevron_right
Neonatal fluid and electrolytes profile effect on amphotericin B associated nephrotoxicity in neonatal tertiary care unit of Karachi-Pakistan
Arjumand Rizvi
Expert Opinion on Drug Safety
View PDFchevron_right
Candidemia in the Neonatal Intensive Care Unit: Insights on Epidemiology and Antifungal Drug Susceptibility Patterns
aliaa ali
Archives of Pediatric Infectious Diseases, 2018
View PDFchevron_right
Cochrane review: Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections
Tracey O'Brien
Evidence-Based Child Health: A Cochrane Review Journal, 2010
View PDFchevron_right
The longest use of liposomal amphotericin B and 5-fluorocytosine in neonatal renal candidiasis
Ihsan Akpınar, Harika Alpay
Pediatric Nephrology, 2004
View PDFchevron_right
Antibiotics and antifungals in Neonatal Intensive Care Units
alessandra atzei
2007
View PDFchevron_right
Minimum inhibitory concentrations of amphotericin B against Candida krusei isolates from a French teaching hospital laboratory: a retrospective study over 8 years
JL Quesada
Mycoses, 2012
View PDFchevron_right
Systematic review on the first line treatment of amphotericin B in critically ill adults with candidemia or invasive candidiasis
Pierce Geoghegan
Expert review of anti-infective therapy, 2018
View PDFchevron_right
Antibiotics and Antifungals in Neonatal Intensive Care Units: A Review
alessandra atzei
Journal of Chemotherapy, 2007
View PDFchevron_right
Amphotericin B-Deoxycholate is as Effective and Safe as the Costly Amphotericin B Colloidal Dispersion in the Treatment of Paediatric Invasive Fungal Infections
Harikrishnan Shanmuganathan
Journal of Pharmacy and Nutrition Sciences, 2014
View PDFchevron_right
Odio CM, Araya R, Pinto LE, et al. Caspofungin therapy of neonates with invasive candidiasis
Luis Pinto, Carla Odio
The Pediatric Infectious Disease Journal
View PDFchevron_right
Persistent Candida conglobata bloodstream infection in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin
Rachel Chandy
Journal de mycologie medicale, 2017
View PDFchevron_right
Renal impairment and Amphotericin B formulations in patients with invasive fungal infections
Bertrand Dupont
Medical Mycology, 2008
View PDFchevron_right
Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients
Elias Iosifidis
Expert Opinion on Pharmacotherapy, 2008
View PDFchevron_right
Successful therapy of Candida pulcherrima fungemia in a premature newborn with liposomal amphotericin B and micafungin
MARIA KIMOULI
Medical Mycology Case Reports, 2016
View PDFchevron_right
Candida Infections in Surgical Patients Dose Requirements and Toxicity of Amphotericin B
Richard Simmons
Annals of Surgery, 1982
View PDFchevron_right
Is There a Therapeutic or Pharmacokinetic Rationale for Amphotericin B Dosing in Systemic Candida Infections?
Chris Gentry
Annals of Pharmacotherapy, 1996
View PDFchevron_right
Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species
Guillermo Quindós, Emilia Canton
Diagnostic Microbiology and Infectious Disease, 2003
View PDFchevron_right
Fungal sepsis and Indications of antifungal prophylaxis and treatment in neonatal intensive care units : A review
Prof. Nazma Yasmeen
Northern International Medical College Journal, 2015
View PDFchevron_right
Invasive candidiasis in pediatric intensive care units
akash deep
Indian Journal of Pediatrics, 2009
View PDFchevron_right
In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections
Juan Berenguer Berenguer
European Journal of Clinical Microbiology & Infectious Diseases, 1995
View PDFchevron_right
Neonatal fungal sepsis by Candida krusei: A report of three cases and a literature review
Selma Lopes
Medical Mycology Case Reports, 2012
View PDFchevron_right
Micafungin Versus Liposomal Amphotericin B for Pediatric Patients With Invasive Candidiasis
Antonio Freire
Pediatric Infectious Disease Journal, 2008
View PDFchevron_right